A phase II study of S-1 plus irinotecan and oxaliplatin in heavily-treated patients with metastatic colorectal cancer

By Kim Sun   Hong Yong   Kim Byung   Park Ji   Choi Hyo   Jeong Seung-Yong   Kim Dae   Hong Chang   Sohn Dae   Jung Kyung  

Investigational New Drugs, Vol. 27, Iss. 3, 2009-06 ,pp. : 269-274

Springer Publishing Company

Access to resources Recommend Favorite

Irinotecan cost effective in metastatic colorectal cancer

By  

Inpharma, Vol. 1, Iss. 1226, 2000-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

Treatment with irinotecan plus cisplatin has a similar survival benefit to etoposide plus cisplatin in patients with extensive-stage small cell lung cancer

By  

Inpharma, Vol. 1, Iss. 1540, 2006-01 ,pp. : 13-13

Adis International

Access to resources Recommend Favorite

Twenty-Eight Years' Survival with Metastatic Phaeochromocytoma Treated by Repeated [131I] Metaiodobenzylguanidine Therapy

By  

Current Radiopharmaceuticals, Vol. 3, Iss. 1, 2010-01 ,pp. : 25-28

Bentham Science Publishers

Access to resources Recommend Favorite

A multi-center phase II study of BMS-247550 (Ixabepilone) by two schedules in patients with metastatic gastric adenocarcinoma previously treated with a taxane

By Ajani J.   Safran H.   Bokemeyer C.   Shah M.   Lenz H.-J.   Cutsem E.   Burris H.   Lebwohl D.   Mullaney B.  

Investigational New Drugs, Vol. 24, Iss. 5, 2006-09 ,pp. : 441-446

Springer Publishing Company

Access to resources Recommend Favorite